• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPOCK1 表达降低通过 Wnt/β-连环蛋白信号通路抑制非小细胞肺癌细胞增殖和迁移。

Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.

机构信息

Department of Thoracic Surgery, Chinese PLA General Hospital, Beijing, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):637-644. doi: 10.26355/eurrev_201802_14288.

DOI:10.26355/eurrev_201802_14288
PMID:29461591
Abstract

OBJECTIVE

Accumulating evidence suggests that SPARC/osteonectin, cwcv, and kazal-like domain proteoglycan 1 (SPOCK1) contributes to the initiation and progression of human cancers. However, little is known about the function mechanisms of SPOCK1 in non-small cell lung cancer (NSCLC). The aim of this study was to investigate the molecular mechanism of SPOCK1 in NSCLC.

PATIENTS AND METHODS

The expression levels of SPOCK1 in NSCLC tissues and cell lines were analyzed by qRT-PCR and Western blotting. The proliferative activity of NSCLC cells was determined by MTT and colony formation assays. The transwell assay was used to examine the cell migration and invasive ability. To study the impact of SPOCK1 on Wnt/β‑catenin signaling, we further performed Western blotting for related proteins in this pathway.

RESULTS

We observed that the expression of SPOCK1 at both protein and mRNA levels was also increased in human NSCLC tissues and cell lines. Functionally, down-regulation of SPOCK1 in NSCLC cells markedly suppressed cell proliferation, colony formation, migration and invasion in vitro. Mechanistically, we found that indicated the activation of Wnt/β-catenin pathway was suppressed by SPOCK1 silencing.

CONCLUSIONS

The expression of SPOCK1 served as a tumor promoter, possibly through the Wnt/β-catenin signaling pathway in NSCLC. Targeting SPOCK1 could be a potential therapeutic strategy in NSCLC.

摘要

目的

越来越多的证据表明,富含半胱氨酸的酸性分泌蛋白(SPARC)/骨粘连蛋白,卷曲螺旋结构域蛋白 1(cwcv)和富含半胱氨酸的 Kazal 型蛋白酶抑制剂 1(SPOCK1)有助于人类癌症的发生和发展。然而,人们对 SPOCK1 在非小细胞肺癌(NSCLC)中的功能机制知之甚少。本研究旨在探讨 SPOCK1 在 NSCLC 中的分子机制。

患者和方法

通过 qRT-PCR 和 Western blot 分析 NSCLC 组织和细胞系中 SPOCK1 的表达水平。MTT 和集落形成实验测定 NSCLC 细胞的增殖活性。Transwell 测定法用于检测细胞迁移和侵袭能力。为了研究 SPOCK1 对 Wnt/β-catenin 信号通路的影响,我们进一步对该通路中的相关蛋白进行了 Western blot 分析。

结果

我们观察到 SPOCK1 的表达在蛋白质和 mRNA 水平上均在人 NSCLC 组织和细胞系中升高。功能上,沉默 SPOCK1 可显著抑制 NSCLC 细胞的体外增殖、集落形成、迁移和侵袭。机制上,我们发现 SPOCK1 沉默抑制了 Wnt/β-catenin 通路的激活。

结论

SPOCK1 的表达作为一种肿瘤促进剂,可能通过 Wnt/β-catenin 信号通路在 NSCLC 中发挥作用。靶向 SPOCK1 可能是 NSCLC 的一种潜在治疗策略。

相似文献

1
Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.SPOCK1 表达降低通过 Wnt/β-连环蛋白信号通路抑制非小细胞肺癌细胞增殖和迁移。
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):637-644. doi: 10.26355/eurrev_201802_14288.
2
SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.SPOCK1通过PI3K/AKT和Wnt/β-连环蛋白信号通路促进胶质瘤细胞的增殖、迁移和侵袭。
Oncol Rep. 2016 Jun;35(6):3566-76. doi: 10.3892/or.2016.4757. Epub 2016 Apr 20.
3
MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.miR-770 通过靶向 JMJD6 并调控非小细胞肺癌中的 WNT/β-catenin 通路抑制肿瘤发生和 EMT。
Life Sci. 2017 Nov 1;188:163-171. doi: 10.1016/j.lfs.2017.09.002. Epub 2017 Sep 4.
4
Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.缺氧诱导因子-2α依赖的核富集转录本1的过表达通过miR-101-3p/SOX9/ Wnt/β-连环蛋白信号通路促进非小细胞肺癌进展。
Cell Physiol Biochem. 2019;52(3):368-381. doi: 10.33594/000000026. Epub 2019 Mar 8.
5
Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.HJURP 的敲低抑制了 Wnt/β-连环蛋白信号通路,从而抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3847-3856. doi: 10.26355/eurrev_201905_17812.
6
BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.BCL9 通过 β-catenin 通路促进顺铂耐药 NSCLC 细胞中的上皮间质转化和侵袭。
Life Sci. 2018 Sep 1;208:284-294. doi: 10.1016/j.lfs.2018.07.023. Epub 2018 Jul 23.
7
miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.miR-192-5p 的上调通过靶向 c-Myc 并使 Wnt/β-连环蛋白信号通路失活来介导姜黄素对人非小细胞肺癌细胞增殖、迁移和侵袭的抑制作用。
Mol Med Rep. 2020 Aug;22(2):1594-1604. doi: 10.3892/mmr.2020.11213. Epub 2020 Jun 4.
8
MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.MicroRNA-625 通过直接靶向 HOXB5 并失活 Wnt/β-catenin 通路抑制非小细胞肺癌的进展。
Int J Mol Med. 2019 Jul;44(1):346-356. doi: 10.3892/ijmm.2019.4203. Epub 2019 May 20.
9
Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.上调的长链非编码RNA SNHG1通过抑制miR-101-3p和激活Wnt/β-连环蛋白信号通路促进非小细胞肺癌进展。
Oncotarget. 2017 Mar 14;8(11):17785-17794. doi: 10.18632/oncotarget.14854.
10
Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.核仁与纺锤体相关蛋白 1 促进非小细胞肺癌进展并作为肌增强因子 2D 的效应物。
Oncol Rep. 2021 Mar;45(3):1044-1058. doi: 10.3892/or.2020.7918. Epub 2020 Dec 30.

引用本文的文献

1
Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer.SPOCK1在非小细胞肺癌及肺癌脑转移形成机制与治疗中的作用
Onco Targets Ther. 2025 Jan 16;18:35-47. doi: 10.2147/OTT.S483576. eCollection 2025.
2
SPOCK: Master regulator of malignant tumors (Review).SPOCK:恶性肿瘤的主调控因子(综述)。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13355. Epub 2024 Oct 11.
3
A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients.
基于免疫细胞浸润景观的新型基因特征可预测肺腺癌患者的预后。
Curr Med Chem. 2024;31(38):6319-6335. doi: 10.2174/0109298673293174240320053546.
4
SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer.SPOCK1过表达提示卵巢癌预后不良。
Cancers (Basel). 2023 Mar 29;15(7):2037. doi: 10.3390/cancers15072037.
5
SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.SPOCK1 和 POSTN 是结直肠癌中有价值的预后生物标志物,与肿瘤免疫浸润相关。
BMC Gastroenterol. 2023 Jan 7;23(1):4. doi: 10.1186/s12876-022-02621-2.
6
Enhancing progestin therapy via HDAC inhibitors in endometrial cancer.通过组蛋白去乙酰化酶抑制剂增强子宫内膜癌的孕激素治疗
Am J Cancer Res. 2022 Nov 15;12(11):5029-5048. eCollection 2022.
7
Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma.鉴定与上皮-间质转化(EMT)相关的特征以分层评估肺腺癌的预后并评估肿瘤微环境。
Front Genet. 2022 Sep 16;13:1008416. doi: 10.3389/fgene.2022.1008416. eCollection 2022.
8
Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma.胃腺癌中 SOX9、MCL-1 和 SPOCK1 的表达及潜在预后价值。
Pathol Oncol Res. 2022 Feb 9;28:1610293. doi: 10.3389/pore.2022.1610293. eCollection 2022.
9
SPOCK1 Promotes the Development of Hepatocellular Carcinoma.SPOCK1促进肝细胞癌的发展。
Front Oncol. 2022 Feb 3;12:819883. doi: 10.3389/fonc.2022.819883. eCollection 2022.
10
miR-940 is a new biomarker with tumor diagnostic and prognostic value.微小RNA-940是一种具有肿瘤诊断和预后价值的新型生物标志物。
Mol Ther Nucleic Acids. 2021 May 8;25:53-66. doi: 10.1016/j.omtn.2021.05.003. eCollection 2021 Sep 3.